08:30–09:15
Registration
The Seno-Therapeutics Summit 2025 will feature a lineup of prominent speakers and thought leaders, alongside distinguished experts participating in the ICSA Meeting.
Vitalist
Vitadao
Founder & CEO
Minicircle
Professor
UCLA
Managing Director
Otsuka Pharmaceutical Italy
CSO & Co-Founder
Oisin Biotechnologies
CEO & Co-Founder
Deciduous Therapeutics
Chief Scientist
Unity Biotechnology
Founder & CEO
Eos SENOLYTIX, Phoenix SENOLYTIX
VP, External Innovation
Eli Lilly and Company
Head, Emerging Sciences
Chiesi Pharmaceuticals
Professor
UT Health San Antonio
…
…
More speakers will be confirmed and announced soon. Stay tuned for updates.
Check out the complete and updated list of distinguished speakers for the 10th ICSA Meeting here.
Keynote Speaker
Program subject to final confirmation. Additional speakers will be announced — stay tuned!
Seno-Therapeutics Summit 2025
Draft Program
Session 1
New Discoveries, Biomarkers & Clinical Trials: A Perspective from Academics
Round Table 1
Biomarkers & Clinical Trial Designs for Senotherapeutics
Round Table 2
Cellular Senescence & Longevity Therapeutics: Are Big Pharma ready to bet on Aging Biology as key driver and mechanism of chronic diseases?
Session 2
Early Stage Companies
Round Table 3
From Gene Delivery to Decentralized Discovery – Translating Senescence Science into the Next Generation of Senotherapeutics
Find all other summit details on our dedicated page: Go To Page
We are thankful to our sponsors for their generous support!
Check out the complete agenda for 10th ICSA Meeting here.